Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Openlabel, Phase II Trial of Abatacept (Orencia) in the Treatment of Refractory Non-infectious Uveitis.

NCT01279954 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT01279954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01279954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Openlabel, Phase II Trial of Abatacept (Orencia) in the Treatment of Refractory Non-infectious Uveitis.
Lead sponsor
Oregon Health and Science University
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2012
Completion date
June 30, 2017
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uveitis